Please use this identifier to cite or link to this item: https://doi.org/10.18632/oncotarget.6723
Title: CD147 regulates cancer migration via direct interaction with Annexin A2 and DOCK3-β-catenin-WAVE2 signaling
Authors: Cui, H.-Y
Wang, S.-J 
Miao, J.-Y
Fu, Z.-G
Feng, F
Wu, J
Yang, X.-M
Chen, Z.-N
Jiang, J.-L
Keywords: beta catenin
CD147 antigen
dedicator of cytokinesis 3 protein
guanine nucleotide exchange factor
lipocortin 2
unclassified drug
WAVE2 protein
ANXA2 protein, human
beta catenin
BSG protein, human
CD147 antigen
CTNNB1 protein, human
DOCK3 protein, human
guanine nucleotide exchange factor
lipocortin 2
messenger RNA
nerve protein
small interfering RNA
WASF2 protein, human
Wiskott Aldrich syndrome protein
A549 cell line
animal experiment
animal model
Article
cell migration
cell motility
cell nucleus
cellular distribution
controlled study
down regulation
hepatocellular carcinoma cell line
human
human cell
human tissue
lamellipodium
liver cell carcinoma
male
metastasis
mouse
nonhuman
protein domain
protein phosphorylation
protein protein interaction
signal transduction
animal
antagonists and inhibitors
apoptosis
Bagg albino mouse
cell motion
cell proliferation
chemistry
drug screening
fluorescent antibody technique
gene expression regulation
genetics
liver tumor
metabolism
nude mouse
pathology
phosphorylation
real time polymerase chain reaction
reverse transcription polymerase chain reaction
secondary
surface plasmon resonance
tumor cell culture
Western blotting
Animals
Annexin A2
Antigens, CD147
Apoptosis
beta Catenin
Blotting, Western
Carcinoma, Hepatocellular
Cell Movement
Cell Proliferation
Fluorescent Antibody Technique
Gene Expression Regulation, Neoplastic
Guanine Nucleotide Exchange Factors
Humans
Liver Neoplasms
Male
Mice
Mice, Inbred BALB C
Mice, Nude
Nerve Tissue Proteins
Phosphorylation
Real-Time Polymerase Chain Reaction
Reverse Transcriptase Polymerase Chain Reaction
RNA, Messenger
RNA, Small Interfering
Signal Transduction
Surface Plasmon Resonance
Tumor Cells, Cultured
Wiskott-Aldrich Syndrome Protein Family
Xenograft Model Antitumor Assays
Issue Date: 2016
Citation: Cui, H.-Y, Wang, S.-J, Miao, J.-Y, Fu, Z.-G, Feng, F, Wu, J, Yang, X.-M, Chen, Z.-N, Jiang, J.-L (2016). CD147 regulates cancer migration via direct interaction with Annexin A2 and DOCK3-β-catenin-WAVE2 signaling. Oncotarget 7 (5) : 5613-5629. ScholarBank@NUS Repository. https://doi.org/10.18632/oncotarget.6723
Rights: Attribution 4.0 International
Abstract: The acquisition of inappropriate migratory feature is crucial for tumor metastasis. It has been suggested that CD147 and Annexin A2 are involved in regulating tumor cell movement, while the regulatory mechanisms are far from clear. In this study, we demonstrated that CD147 physically interacted with the N-terminal domain of Annexin A2 and decreased Annexin A2 phosphorylation on tyrosine 23. In vitro kinase assay showed that the I domain of CD147 was indispensable for CD147-mediated downregulation of Annexin A2 phosphorylation by Src. Furthermore, we determined that p-Annexin A2 promoted the expression of dedicator of cytokinesis 3 (DOCK3) and DOCK3 blocked β-catenin nuclear translocation, resulting in inhibition of β-catenin signaling. In addition, DOCK3 inhibited lamellipodium dynamics and tumor cell movement. Also, we found that β-catenin signaling increased WAVE2 expression. Therefore, DOCK3 was characterized as a negative regulator of WAVE2 expression via inhibiting β-catenin signaling. Our study provides the first evidence that CD147 promotes tumor cell movement and metastasis via direct interaction with Annexin A2 and DOCK3-β-catenin-WAVE2 signaling axis.
Source Title: Oncotarget
URI: https://scholarbank.nus.edu.sg/handle/10635/180863
ISSN: 19492553
DOI: 10.18632/oncotarget.6723
Rights: Attribution 4.0 International
Appears in Collections:Elements
Staff Publications

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_18632_oncotarget_6723.pdf6.56 MBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons